{"nct_id":"NCT02213263","title":"A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2014-09-30","start_date_type":"ACTUAL","primary_completion_date":"2017-10-23","primary_completion_date_type":"ACTUAL","completion_date":"2018-04-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}